Scientists find a new hope for neuropathic pain relief

Credit: Unsplash+

In the world of medicine, there’s a big step forward in treating a tough kind of pain known as neuropathic pain.

This kind of pain is different and harder to treat than the usual aches and pains. It’s often caused by nerve damage, and people who have it describe it as feeling like electric shocks, tingling, burning, or even like they’re being stabbed.

Neuropathic pain can come from various conditions like diabetes, multiple sclerosis, the effects of chemotherapy, injuries, or even after someone has had a part of their body amputated. It’s a worldwide problem, affecting millions, and it doesn’t always go away.

The painkillers we have now aren’t always good enough, and they can have bad side effects, including the risk of getting addicted.

But there’s good news from the researchers at The University of Texas at Austin, The University of Texas at Dallas, and the University of Miami. They’ve found a special molecule that really helps with this pain in mice.

This molecule works by sticking to a specific protein that’s involved in neuropathic pain. Their research is so promising that it’s been published in a big-deal journal called Proceedings of the National Academy of Sciences.

Stephen Martin, one of the main authors of the study, shared how effective this new discovery is. He said it works really well on different types of neuropathic pain, like the kind caused by diabetes or chemotherapy.

And what’s super cool about this new compound, called FEM-1689, is that it doesn’t work like opioid painkillers. That means it could be a safer option without the risk of addiction.

FEM-1689 is not just about reducing pain. It also helps with something called the integrated stress response (ISR). This ISR is like a system in our bodies that helps us heal from injuries and deal with diseases.

When the ISR works well, it helps us get better. But if it doesn’t work right, it can actually make things worse, leading to problems like cancer, diabetes, and other disorders.

The team’s goal is to turn FEM-1689 into a real drug that can treat chronic pain without the problems that come with opioids. Neuropathic pain can really change a person’s life, and a well-tolerated and effective treatment is what they’re aiming for.

Theodore Price, another key author, highlighted how this research is a great example of teamwork in academic drug discovery. It’s a big push in the field of non-opioid pain treatments.

In simple terms, this research could be a game-changer for people living with neuropathic pain. It offers hope for a future where pain relief is effective, safer, and without the risk of addiction.

If you care about pain, please read studies about vitamin K deficiency linked to hip fractures in old people, and these vitamins could help reduce bone fracture risk.

For more information about wellness, please see recent studies that Krill oil could improve muscle health in older people, and eating yogurt linked to lower frailty in older people.

The research findings can be found in PNAS.

Copyright © 2024 Knowridge Science Report. All rights reserved.